CLINICAL_TRIALS
trial_result
· 2017-03-29
Clinical Trial Update: Trial of Pimasertib in Hematological Malignancies [Phase 2]
Summary
Phase 2 trial of pimasertib in acute myeloid leukemia and other hematologic neoplasms was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Leukemia, Myeloid, Acute, Hematologic Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2017-03-29